The latest report by IMARC Group, titled “Artificial Intelligence in Healthcare Market Report by Offering (Hardware, Software, Services), Technology (Machine Learning, Context Aware Computing, Natural Language Processing, and Others), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), End-User (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Patients, and Others), and Region 2024-2032“, The global artificial intelligence in healthcare market size reached US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.2 Billion by 2032, exhibiting a growth rate (CAGR) of 27.4% during 2024-2032.

Factors Affecting the Growth of the Artificial Intelligence in the Healthcare Industry:

Rising Demand for Personalized Medicine:

Personalized medicine represents a shift in healthcare, aiming to tailor medical treatment to the individual characteristics of each patient. This approach utilizes a wide array of data sources including genetic information, medical history, lifestyle factors, and more. Additionally, artificial intelligence (AI) technologies are pivotal in this endeavor, as they excel in analyzing and integrating diverse datasets to derive insights that support personalized healthcare decisions. Moreover, healthcare professionals can interpret complex data more efficiently, leading to improved diagnostic accuracy and optimized treatment outcomes by leveraging AI. Along with this, the rising demand for personalized medicine underscores the growing recognition of the unique healthcare needs of individuals and the potential of AI to revolutionize how healthcare is delivered and optimized on an individual basis.

Advancements in AI Algorithms:

The field of AI is witnessing continuous advancements across various domains such as machine learning, deep learning, natural language processing (NLP), and computer vision, all of which are significantly enhancing its capabilities in healthcare. These advancements enable AI algorithms to process and interpret complex medical data with unprecedented accuracy and speed. Additionally, in healthcare, AI algorithms are widely employed to analyze diverse datasets including medical images such as MRI scans, X-rays, genomic data, electronic health records (EHRs), and clinical notes. For instance, deep learning models can detect anomalies in medical images with high precision, while NLP algorithms can extract valuable insights from unstructured clinical text. These capabilities assist healthcare professionals in making informed decisions and contribute to advancements in disease diagnosis, treatment planning, and patient care management. As AI algorithms continue to evolve, they hold promise for further revolutionizing healthcare by unlocking new insights and improving healthcare outcomes through data-driven approaches.

Growing Public Awareness and Acceptance:

There is a noticeable shift in healthcare professionals and the general public toward recognizing the transformative potential of AI in healthcare delivery. As AI applications in healthcare demonstrate tangible benefits, including improved diagnostic accuracy, personalized treatment recommendations, and operational efficiencies, acceptance and adoption are steadily increasing across the healthcare ecosystem. Additionally, healthcare providers are integrating AI-powered tools into their practices to enhance decision-making processes and patient care outcomes. Moreover, patients are becoming more aware of and receptive to AI-driven healthcare solutions, particularly those that promise personalized treatments and better outcomes. This growing awareness and acceptance are further fueled by success stories and case studies showcasing AI's ability to augment human expertise and improve healthcare delivery across the globe.

Competitive Landscape with Key Player:

1. Amazon Web Services Inc.

2. Cloudmedx Inc.

3. DeepMind

4. Enlitic Inc.

5. General Vision Inc.

6. Google Inc.

7. International Business Machines

8. iCarbonX

9. Intel Corporation

10. Medtronic

11. Micron Technology Inc.

12. Microsoft Corporation

13. Next It Corporation

14. Nuance Communications Inc.

15. Nvidia Corporation

16. Siemens Healthcare

17. Welltok Inc.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/artifical-intelligence-healthcare-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Offering:

1. Hardware

2. Software

3. Services

Software represents the largest segment as it enables various AI applications in healthcare, such as diagnostic tools, patient monitoring systems, and administrative software.

Breakup by Technology:

1. Machine Learning

2. Context-Aware Computing

3. Natural Language Processing

4. Others

Machine learning accounts for the largest market share due to its ability to analyze complex medical data, improve diagnostics, personalize treatment plans, and enhance operational efficiency.

Breakup by Application:

1. Robot-Assisted Surgery

2. Virtual Nursing Assistant

3. Administrative Workflow Assistance

4. Fraud Detection

5. Dosage Error Reduction

6. Clinical Trial Participant Identifier

7. Preliminary Diagnosis

8. Others

Clinical trial participant identifiers dominate the market growth as they streamline patient recruitment, ensure trial integrity, and comply with regulatory requirements, crucial for drug development.

Breakup by End-User:

1. Healthcare Providers

2. Pharmaceutical and Biotechnology Companies

3. Patients

4. Others

Pharmaceutical and biotechnology hold the largest market share as they extensively use AI for drug discovery, clinical trials, and regulatory approvals, aiming to accelerate innovation and reduce costs.

Market Breakup by Region:

1. North America (United States, Canada)

2. Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

3. Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

4. Latin America (Brazil, Mexico, Others)

5. Middle East and Africa

North America’s dominance in artificial intelligence in the healthcare market is attributed to strong investments in healthcare infrastructure, advanced technological adoption, supportive regulatory frameworks, and a high prevalence of chronic diseases driving AI adoption in healthcare.

Global Artificial Intelligence in the Healthcare Market Trends:

At present, AI-powered virtual assistants and chatbots are being used to provide basic medical advice, schedule appointments, and offer patient monitoring between visits. These tools enhance patient engagement and streamline administrative tasks for healthcare providers. Moreover, AI is revolutionizing the pharmaceutical industry by accelerating drug discovery processes. Machine learning models can analyze molecular structures, predict the effectiveness of potential drugs, and identify new uses for existing medications. Besides, AI applications are emerging in the field of mental health, including virtual therapists and AI-based tools for early detection of mental health conditions based on speech or text analysis.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145